Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay | Zendy

Rossella Marcucci | Zendy; Anna Maria Gori | Zendy; Rita Paniccia | Zendy; Betti Giusti | Zendy; Serafina Valente | Zendy; Cristina Giglioli | Zendy; Piergiovanni Buonamici | Zendy; David Antoniucci | Zendy; Rosanna Abbate | Zendy; Gian Franco Gensini | Zendy

Open Access

Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay

Author(s) -

Rossella Marcucci,

Anna Maria Gori,

Rita Paniccia,

Betti Giusti,

Serafina Valente,

Cristina Giglioli,

Piergiovanni Buonamici,

David Antoniucci,

Rosanna Abbate,

Gian Franco Gensini

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.812636

Subject(s) - medicine , clopidogrel , percutaneous coronary intervention , cardiology , acute coronary syndrome , myocardial infarction , p2y12 , aspirin , ejection fraction , stent , conventional pci , heart failure

The clinical impact of platelet aggregation assessed by point-of-care assays is unknown. We sought to evaluate whether high residual platelet reactivity (RPR) to ADP during clopidogrel therapy, measured by a point-of-care assay, predicts adverse clinical events in acute coronary syndrome patients undergoing percutaneous coronary intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research